Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 2
2016 1
2017 3
2018 2
2019 5
2020 8
2021 5
2022 7
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis.
Refardt J, Imber C, Sailer CO, Jeanloz N, Potasso L, Kutz A, Widmer A, Urwyler SA, Ebrahimi F, Vogt DR, Winzeler B, Christ-Crain M. Refardt J, et al. Among authors: ebrahimi f. J Am Soc Nephrol. 2020 Mar;31(3):615-624. doi: 10.1681/ASN.2019090944. Epub 2020 Feb 4. J Am Soc Nephrol. 2020. PMID: 32019783 Free PMC article. Clinical Trial.
Dyslipidaemia and growth hormone deficiency - A comprehensive review.
Hepprich M, Ebrahimi F, Christ E. Hepprich M, et al. Among authors: ebrahimi f. Best Pract Res Clin Endocrinol Metab. 2023 Dec;37(6):101821. doi: 10.1016/j.beem.2023.101821. Epub 2023 Sep 15. Best Pract Res Clin Endocrinol Metab. 2023. PMID: 37821339 Review.
Metabolic syndrome and hypogonadism--two peas in a pod.
Ebrahimi F, Christ-Crain M. Ebrahimi F, et al. Swiss Med Wkly. 2016 Mar 21;146:w14283. doi: 10.4414/smw.2016.14283. eCollection 2016. Swiss Med Wkly. 2016. PMID: 26999489 Free article. Review.
Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes.
Schernthaner G, Shehadeh N, Ametov AS, Bazarova AV, Ebrahimi F, Fasching P, Janež A, Kempler P, Konrāde I, Lalić NM, Mankovsky B, Martinka E, Rahelić D, Serafinceanu C, Škrha J, Tankova T, Visockienė Ž. Schernthaner G, et al. Among authors: ebrahimi f. Cardiovasc Diabetol. 2020 Oct 23;19(1):185. doi: 10.1186/s12933-020-01154-w. Cardiovasc Diabetol. 2020. PMID: 33097060 Free PMC article. Review.
50 results